# Levetiracetam for Benign Rolandic Epilepsy

> **NCT00181116** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 6 (—)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00181116
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 6 (—)
- **Last updated:** 2009-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181116, "Levetiracetam for Benign Rolandic Epilepsy". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00181116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*